Michael Zhuoran Xu
Lawyers
Filters
Genetron $126 million going-private transaction
We are separately advising Genetron and the special committee of its board on the transaction
Sirio Pharma acquisition of a majority stake of Best Formulations
We advised Sirio Pharma on the acquisition
Esco Aster spinoff transactions
We are advising Esco Lifesciences on the spinoff
InSilico Medicine $35 million Series D2 financing
We are advising InSilico Medicine on the financing
InSilico Medicine $60 million Series D financing
We are advising InSilico Medicine in connection with its $60 million Series D financing
Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Yili Group HK$6.25 billion acquisition of 34.33% of Ausnutria Dairy
We advised Yili on the acquisition of a controlling interest in Ausnutria
Kingsoft Cloud acquisition of controlling interests in Camelot
We are advising Kingsoft Cloud in connection with the acquisition
Ingram Micro $7.2 billion acquisition by Platinum Equity
We advised Ingram Micro on the transaction
Yili Group HK$1.66 billion privatization of China ZhongDi Dairy
We advised Yili, the largest dairy company in China, on the takeover and delisting of ZhongDi from the HKEX